{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:27:57Z","timestamp":1795159677485,"version":"4.10.3"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/mpa.0000000000000335","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T20:20:46Z","timestamp":1430511646000},"page":"756-763","source":"Crossref","is-referenced-by-count":85,"title":["Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels"],"prefix":"10.1097","volume":"44","author":[{"given":"Tomofumi","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Furuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayumi","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-05-0185","article-title":"Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.","volume":"11","author":"Martignoni","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/bjc.1996.137","article-title":"Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.","volume":"73","author":"Stouthard","year":"1996","journal-title":"Br J Cancer"},{"key":"R3-10-20210212","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2007-2223","article-title":"Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals.","volume":"93","author":"van Hall","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-10-20210212","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1210\/jc.2002-021687","article-title":"Interleukin-6 stimulates lipolysis and fat oxidation in humans.","volume":"88","author":"van Hall","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-10-20210212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jjco\/28.1.12","article-title":"Elevated serum interleukin-6 levels in patients with pancreatic cancer.","volume":"28","author":"Okada","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"R6-10-20210212","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/cncr.20672","article-title":"Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.","volume":"101","author":"Ebrahimi","year":"2004","journal-title":"Cancer"},{"key":"R7-10-20210212","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10620-008-0390-z","article-title":"Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.","volume":"54","author":"Talar-Wojnarowska","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R8-10-20210212","first-page":"473","article-title":"Tumor size and lymph-node status in pancreatic carcinomais there a correlation to the preoperative immune function Langenbecks Arch Surg.","volume":"384","author":"Wenger","year":"1999","journal-title":""},{"key":"R9-10-20210212","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","article-title":"Cancer and systemic inflammation: treat the tumour and treat the host.","volume":"110","author":"Roxburgh","year":"2014","journal-title":"Br J Cancer"},{"key":"R10-10-20210212","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"key":"R11-10-20210212","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R12-10-20210212","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/bjc.2013.174","article-title":"Serum levels of IL-6 and IL-1 can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer.","volume":"108","author":"Mitsunaga","year":"2013","journal-title":"Br J Cancer"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s00268-002-6232-9","article-title":"Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice.","volume":"26","author":"Padillo","year":"2002","journal-title":"World J Surg"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R15-10-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpainsymman.2007.03.009","article-title":"Plasma interleukin-6 and fatigue in terminally ill cancer patients.","volume":"35","author":"Inagaki","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0885-3924(02)00596-1","article-title":"Validation study of the Japanese version of the brief fatigue inventory.","volume":"25","author":"Okuyama","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R17-10-20210212","first-page":"1427","article-title":"Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.","volume":"19","author":"Zhang","year":"1999","journal-title":"Anticancer Res"},{"key":"R18-10-20210212","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02361238","article-title":"Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis.","volume":"29","author":"Ueda","year":"1994","journal-title":"J Gastroenterol"},{"key":"R19-10-20210212","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/j.1349-7006.2012.02411.x","article-title":"Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head.","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"R20-10-20210212","doi-asserted-by":"crossref","first-page":"R1067","DOI":"10.1152\/ajpregu.00320.2011","article-title":"Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma.","volume":"302","author":"Benson","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10585-011-9419-3","article-title":"Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver.","volume":"28","author":"Thomas","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cellsig.2009.01.006","article-title":"The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis.","volume":"21","author":"Paschos","year":"2009","journal-title":"Cell Signal"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.93.26.15364","article-title":"Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle.","volume":"93","author":"Rooyackers","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-10-20210212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jso.2930570211","article-title":"Diminished visceral adipose tissue in cancer cachexia.","volume":"57","author":"Ogiwara","year":"1994","journal-title":"J Surg Oncol"},{"key":"R25-10-20210212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/cs0890431","article-title":"Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes.","volume":"89","author":"Ebisui","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"R26-10-20210212","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/cncr.22328","article-title":"Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.","volume":"107","author":"Krishnan","year":"2006","journal-title":"Cancer"},{"key":"R27-10-20210212","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1542-3565(04)00171-5","article-title":"Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area.","volume":"2","author":"Holly","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-10-20210212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1997.17","article-title":"Changes in nutritional status associated with unresectable pancreatic cancer.","volume":"75","author":"Wigmore","year":"1997","journal-title":"Br J Cancer"},{"key":"R29-10-20210212","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00520-012-1514-8","article-title":"Symptoms in advanced pancreatic cancer are of importance for energy intake.","volume":"21","author":"Bye","year":"2013","journal-title":"Support Care Cancer"},{"key":"R31-10-20210212","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00520-008-0512-3","article-title":"Associations between quality of life, fatigue, and cytokine levels in patients aged 50 with acute myeloid leukemia.","volume":"17","author":"Panju","year":"2009","journal-title":"Support Care Cancer"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbi.2010.03.009","article-title":"Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.","volume":"24","author":"Wang","year":"2010","journal-title":"Brain Behav Immun"},{"key":"R33-10-20210212","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbi.2011.12.007","article-title":"Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.","volume":"26","author":"Wang","year":"2012","journal-title":"Brain Behav Immun"},{"key":"R34-10-20210212","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.1840120517","article-title":"Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6.","volume":"12","author":"Castell","year":"1990","journal-title":"Hepatology"},{"key":"R35-10-20210212","first-page":"E720","article-title":"Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes.","volume":"273","author":"Wigmore","year":"1997","journal-title":"Am J Physiol"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism.","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu Rev Med"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajh.23110","article-title":"Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.","volume":"87","author":"Sun","year":"2012","journal-title":"Am J Hematol"},{"key":"R38-10-20210212","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2005-03-1159","article-title":"Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.","volume":"106","author":"Kemna","year":"2005","journal-title":"Blood"},{"key":"R39-10-20210212","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2008-08-173641","article-title":"Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli.","volume":"113","author":"Huang","year":"2009","journal-title":"Blood"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:10Z","timestamp":1620963430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201507000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000335","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}